By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



29 Newbury Street

Boston  Massachusetts  02116  U.S.A.
Phone: 617-236-0535 Fax: 617-249-0490


Start Up

Company News
Zafgen (ZFGN) Reports First Quarter 2017 Financial Results 5/10/2017 8:04:09 AM
Struggling Zafgen (ZFGN) Catches A Break With Promising Early-Stage Obesity Data 5/5/2017 5:43:04 AM
Zafgen (ZFGN) To Host Conference Call To Discuss Fourth Quarter And Full Year 2016 Financial Results 3/3/2017 8:49:37 AM
Zafgen (ZFGN) Reports Third Quarter 2016 Financial Result 11/10/2016 8:20:48 AM
Zafgen (ZFGN) Initiates Multiple Ascending Dose Cohorts In Phase I Clinical Trial Of ZGN-1061 9/20/2016 7:55:35 AM
Zafgen (ZFGN) Reports Second Quarter 2016 Financial Results 8/5/2016 8:46:02 AM
Zafgen (ZFGN) To Present At Canaccord Genuity’s 36th Annual Growth Conference 8/4/2016 8:19:19 AM
Zafgen (ZFGN) Pinks Slips 34% of Workforce, Scraps Lead Obesity Drug After Deaths 7/20/2016 6:19:16 AM
Zafgen (ZFGN)'s Alicia Secor Steps Up as Juniper Pharma (JNP)’s President and CEO 7/20/2016 5:42:21 AM
Zafgen (ZFGN) Presents New Data From The Phase IIb Clinical Trial Evaluating Beloranib In Severe Obesity Complicated By Type 2 Diabetes At The American Diabetes Association's 76th Scientific Sessions 6/13/2016 7:48:46 AM